Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
Filter | Charlie Hatton | |||||||
GSE232007 |
Mezigdomide is effective alone and in combination with Menin inhibition in pre-clinical models of KMT2A-r and NPM1c AML
|
9 | Charlie Hatton | Feb 20, 2024 | ||||
GSE196476 |
Mutant NPM1 binds chromatin and directly regulates oncogenic transcription in acute myeloid leukemia [ChIP-seq]
|
126 | Charlie Hatton | Jan 30, 2023 | ||||
GSE196477 |
Mutant NPM1 binds chromatin and directly regulates oncogenic transcription in acute myeloid leukemia [RNA-seq]
|
24 | Charlie Hatton | Jan 30, 2023 | ||||
GSE196478 |
Mutant NPM1 binds chromatin and directly regulates oncogenic transcription in acute myeloid leukemia [PRO-seq]
|
10 | Charlie Hatton | Jan 30, 2023 | ||||
GSE196479 |
Mutant NPM1 binds chromatin and directly regulates oncogenic transcription in acute myeloid leukemia [SLAM-seq]
|
18 | Charlie Hatton | Jan 30, 2023 | ||||
GSE196480 |
Mutant NPM1 binds chromatin and directly regulates oncogenic transcription in acute myeloid leukemia
|
178 | Charlie Hatton | Jan 30, 2023 | ||||
GSE175594 |
The MLL-Menin interaction is a molecular dependency in NUP98-rearranged AML [BioChIP-seq]
|
3 | Charlie Hatton | Jun 01, 2022 | ||||
GSE175595 |
The MLL-Menin interaction is a molecular dependency in NUP98-rearranged AML [ChIP-Seq]
|
24 | Charlie Hatton | Jun 01, 2022 | ||||
GSE175596 |
The MLL-Menin interaction is a molecular dependency in NUP98-rearranged AML [RNA-Seq]
|
57 | Charlie Hatton | Jun 01, 2022 | ||||
GSE175597 |
The MLL-Menin interaction is a molecular dependency in NUP98-rearranged AML
|
84 | Charlie Hatton | Jun 01, 2022 | ||||
GSE168459 |
IKAROS and MENIN are Functionally Cooperative Therapeutic Targets in Acute Myeloid Leukemia [ATAC-seq]
|
2 | Charlie Hatton | Mar 10, 2022 | ||||
GSE168460 |
IKAROS and MENIN are Functionally Cooperative Therapeutic Targets in Acute Myeloid Leukemia [CUT&RUN]
|
14 | Charlie Hatton | Mar 10, 2022 | ||||
GSE168461 |
IKAROS and MENIN are Functionally Cooperative Therapeutic Targets in Acute Myeloid Leukemia [ChIP-seq]
|
10 | Charlie Hatton | Mar 10, 2022 | ||||
GSE168462 |
IKAROS and MENIN are Functionally Cooperative Therapeutic Targets in Acute Myeloid Leukemia [RNA-seq]
|
61 | Charlie Hatton | Mar 10, 2022 | ||||
GSE168463 |
IKAROS and MENIN are Functionally Cooperative Therapeutic Targets in Acute Myeloid Leukemia
|
87 | Charlie Hatton | Mar 10, 2022 | ||||
GSE173571 |
Chromatin state changes induced by targeted degradation of MLL-AF9 are phenocopied by combined DOT1L and MENIN inhibition. [SLAM-Seq]
|
15 | Charlie Hatton | Mar 03, 2022 | ||||
GSE173574 |
Chromatin state changes induced by targeted degradation of MLL-AF9 are phenocopied by combined DOT1L and MENIN inhibition. [RNA-Seq]
|
84 | Charlie Hatton | Mar 03, 2022 | ||||
GSE173599 |
Chromatin state changes induced by targeted degradation of MLL-AF9 are phenocopied by combined DOT1L and MENIN inhibition. [ChIP-Seq]
|
75 | Charlie Hatton | Mar 03, 2022 | ||||
GSE173600 |
Chromatin state changes induced by targeted degradation of MLL-AF9 are phenocopied by combined DOT1L and MENIN inhibition.
|
186 | Charlie Hatton | Mar 03, 2022 | ||||
GSE189098 |
Chromatin state changes induced by targeted degradation of MLL-AF9 are phenocopied by combined DOT1L and MENIN inhibition [ATAC-seq]
|
4 | Charlie Hatton | Mar 03, 2022 |